Flurry of Acquisitions and Licensing Deals Come Amid JP Morgan Healthcare Conference 2025

Organizations including Gilead, Eli Lilly, and AbbVie announced a number of deals addressing inflammatory diseases, multiple myeloma, and other disease areas.